Cellectar Biosciences, Inc. ( CLRB) - Stock Earnings
CLRB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
CLRB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -4.4 million USD | — USD |
| 2025Q4 | -5.3 million USD | — USD |
| 2026Q1 | -5.7 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
CLRB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -42.8 million USD | — USD |
| 2024 | -44.6 million USD | — USD |
| 2025 | -21.8 million USD | — USD |
| 2026 Est. | — | — |
CLRB
Price: $2.41
52 week price:
Earnings Per Share: -5.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 27300
Ebitda: -3.4 millionMarket Capitalization: 8.5 million